Key result
Admission glucose, fasting glucose, and HbA1c show potential impact on 5-year in-stent restenosis after primary PCI.
Why the study?
In-stent restenosis remains a major problem after PCI, and the impact of admission blood glucose, fasting glucose, and HbA1c levels on ISR in STEMI patients is not fully understood.
Key points are not available for this paper at this time.
Population
264 STEMI patients who underwent primary PCI with control coronary angiography during 5-year follow-up
Comparison
ISR group vs non-ISR group, diabetic vs non-diabetic subgroups
Design
Retrospective analysis of hospital digital records
Follow-up
5 years
Answers are grounded in this paper and cite their sources.
Glucose metrics' link to 5-year restenosis after primary PCI remains uncertain; larger prospective studies needed before clinical use.
Conclusion: This study results showed that in diabetic STEMI patients who underwent primary PCI, higher HbA1c levels were associated with higher ISR rates, but not with FBG and ABG levels. Results: There were 127 patients in the ISR group (diabetic: 36 non-diabetic: 91) and 137 patients in the non-ISR group (diabetic: 43 non-diabetic: 94). Regardless of the patients diabetes status, no significant difference was found between the groups with and without ISR in terms of HbA1c, FBG and ABG. A significant relationship was found between the baseline HbA1c value and having ISR only in the diabetic subgroup (p=0.01). Methods: From 2.900 patients who underwent coronary stent implantation for STEMI from January 2008 through December 2012 were retrospectively analyzed through the hospital digital recording system. Of these, 264 patients who underwent control coronary angiography during the five-year follow-up were included in the study. Patients were divided into two main group ISR and non-ISR; were divided into two subgroups diabetic and non-diabetic groups were compared with HbA1c, ABG, FBG and angiographic parameters. Aim: Despite advances in-stent technology, in-stent restenosis (ISR) is still a major problem following percutaneous coronary intervention (PCI) and its reasons have not been fully revealed. In the presented study, we investigated the effect of admission blood glucose (ABG), fasting blood glucose (FBG) and glycated hemoglobin A1c (HbA1c) levels on coronary ISR patients with ST-elevation myocardial infarction (STEMI) who underwent primary PCI in five-year follow-up.
No takes yet. Share an insight, caveat, or question.
Karadeniz et al. (2021) studied this question. Admission glucose, fasting glucose, and HbA1c levels were evaluated for their impact on in-stent restenosis over 5 years in patients treated with primary percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: